232 related articles for article (PubMed ID: 11465725)
1. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.
Kawaguchi Y; Terajima H; Harigai M; Hara M; Kamatani N
Arthritis Rheum; 2001 Jul; 44(7):1716-7. PubMed ID: 11465725
[No Abstract] [Full Text] [Related]
2. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
[TBL] [Abstract][Full Text] [Related]
3. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Zou YQ; Lu LJ; Li SJ; Zeng T; Wang XD; Bao CD; Chen SL; Yang CD
Clin Biochem; 2008 May; 41(7-8):519-24. PubMed ID: 18261992
[TBL] [Abstract][Full Text] [Related]
4. Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile.
Saiki O; Uda H; Nishimoto N; Miwa T; Mima T; Ogawara T; Azuma N; Katada Y; Sawaki J; Tsutsui H; Matsui K; Maeda A; Nakanishi K
Clin Immunol; 2004 Jul; 112(1):120-5. PubMed ID: 15207789
[TBL] [Abstract][Full Text] [Related]
5. [Ferritin levels in adult Still's disease].
Flatau E; Reichman N; Kaufman N
Harefuah; 1999 Sep; 137(5-6):200-1, 263, 262. PubMed ID: 10959321
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of adult-onset Still's disease: contribution of biology].
Garcia-Hejl C; Vest P; Garcia C; Renard C; Revenant MC; Thefenne-Astier H; Berets O
Ann Biol Clin (Paris); 2007; 65(3):303-7. PubMed ID: 17502305
[TBL] [Abstract][Full Text] [Related]
7. The associations of circulating CD4+CD25high regulatory T cells and TGF-β with disease activity and clinical course in patients with adult-onset Still's disease.
Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
Connect Tissue Res; 2010 Oct; 51(5):370-7. PubMed ID: 20388015
[TBL] [Abstract][Full Text] [Related]
8. Lymph node IL-18 expression in adult-onset Still's disease.
Conigliaro P; Priori R; Bombardieri M; Alessandri C; Barone F; Pitzalis C; McInnes IB; Valesini G
Ann Rheum Dis; 2009 Mar; 68(3):442-3. PubMed ID: 19213748
[No Abstract] [Full Text] [Related]
9. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
10. Extremely high serum ferritin levels as diagnostic tool in adult-onset Still's disease.
Meijvis SC; Endeman H; Geers AB; ter Borg EJ
Neth J Med; 2007 Jun; 65(6):212-4. PubMed ID: 17587648
[TBL] [Abstract][Full Text] [Related]
11. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
12. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.
Usuda D; Furumura Y; Takeshima K; Sangen R; Kawai Y; Kasamaki Y; Iinuma Y; Kanda T
J Med Case Rep; 2018 Jul; 12(1):198. PubMed ID: 29986752
[TBL] [Abstract][Full Text] [Related]
14. Adult-onset Still's disease.
Talreja D; Jirjis JN
Tenn Med; 1998 May; 91(5):186-7. PubMed ID: 9584607
[No Abstract] [Full Text] [Related]
15. A Japanese case of severe refractory adult Still's disease: serum interleukin-18 is a possible marker of the response to low-dose cyclosporin A therapy.
Sawayama Y; Nabeshima S; Taniai H; Furusyo N; Kashiwagi S; Hayashi J
Fukuoka Igaku Zasshi; 2002 Sep; 93(9):189-95. PubMed ID: 12426765
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease.
Komiya A; Matsui T; Nogi S; Iwata K; Futami H; Takaoka H; Arinuma Y; Hashimoto A; Shimada K; Ikenaka T; Nakayama H; Furukawa H; Tohma S
Scand J Rheumatol; 2012 Mar; 41(2):156-8. PubMed ID: 22420333
[No Abstract] [Full Text] [Related]
17. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease.
Ogata A; Kitano M; Yamanaka J; Yamasaki T; Hashimoto N; Iwasaki T; Hamano T; Fujimoto J; Kakishita E
J Rheumatol; 2003 May; 30(5):1093-6. PubMed ID: 12734913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
